SECTION 3. SECURITIES AND TRADING MARKETS Item 3.02 Unregistered Sales of Equity Securities. Xechem International, Inc. has received an aggregate of approximately $459,000 of subscription proceeds in connection with its issuance of a new tranche of Units comprised of convertible debentures plus warrants to purchase 75% of the shares of common stock purchasable on conversion of the original principal amount of the debentures. The debentures are substantially similar to those issued in connection with its Units offering completed in April, 2007, except that they are convertible into Common Stock at a lower per share price ($0.001 per share), mature October 31, 2009, are not secured by a pledge of any of the assets of Dr. Pandey, and were issued outright rather than pursuant to a purchase agreement containing extensive representations and warranties of the Company. The warrants are also exercisable at $0.001 per share. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Xechem International, Inc. By: /s/Robert Swift Robert Swift, Chief Oversight Officer Dated: December 24, 2007 </TEXT> </DOCUMENT>